 |
|
September 2011
|
HOUSE, SENATE AT ODDS OVER NIH, NCI FUNDING
New House proposal puts research funding at center of broader FY2012 budget debate
In a move that took many by surprise, Republican leaders in the House yesterday released a draft proposal that would increase fiscal year 2012 funding for the National Institutes of Health (NIH) and the National Cancer Institute (NCI), just days after Democrats in the Senate voted to cut funds for the research agencies. Read more
AACR EVENTS BRING NCI, FDA LEADERS TO CAPITOL HILL
Varmus and Woodcock engage legislators in discussions about cancer research priorities
Following the release of the landmark Cancer Progress Report 2011, the AACR continued the momentum last week by sponsoring two congressional briefings. The events brought National Cancer Institute (NCI) Director Harold Varmus, M.D., and Janet Woodcock, M.D., director of the Office of Drug Evaluation and Research (CDER) at the U.S. Food and Drug Administration (FDA), to Capitol Hill where they discussed issues affecting cancer research with legislators and key policy aides. Read more
LAWMAKERS EXAMINE GROWING PROBLEM OF DRUG SHORTAGES
AACR member testifies about detrimental impact of shortages on cancer research and care
Shortages of certain pharmaceuticals have concerned clinicians and researchers for several years, and the problem has continued to worsen. The issue has now reached the point that it has captured the attention of Congress, leading a key House panel to hold a hearing entitled “Examining Increases in of Drug Shortages” on September 23. Read more
AACR HONORS CONGRESSIONAL SUPPORTERS OF NIH RESEARCH
Moran, Platts, Wasserman-Schultz recognized with Distinguished Public Service Awards
The AACR celebrated three leaders in Congress last week for their commitment and dedication to the conquest of cancer. Sen. Jerry Moran (R-Kan.), Rep. Debbie Wasserman Schultz (D-Fla.) and Rep. Todd Platts (R-Penn.) were each honored with an AACR Distinguished Public Service Award during a reception on Capitol Hill, which took place during a full week of events in Washington, D.C., organized by the AACR to draw attention to the importance of investment in cancer research and encourage continued congressional support for the National Institutes of Health. Read more
Top